Company Filing History:
Years Active: 2003-2004
Title: Per-Åke Nygren: Innovator in Bacterial Receptor Structures
Introduction
Per-Åke Nygren is a notable inventor based in Skarpnäck, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of bacterial receptor structures. With a total of 3 patents to his name, Nygren's work has implications for various applications in medicine and research.
Latest Patents
Nygren's latest patents include groundbreaking inventions such as bacterial receptor structures. This patent focuses on novel proteins obtainable by mutagenesis of surface-exposed amino acids of domains of natural bacterial receptors. These proteins are designed to be obtained without substantial loss of the basic structure and stability of the natural bacterial receptors. Additionally, he has developed methods for the manufacture of artificial bacterial receptor structures. Another significant patent involves modified polypeptide derivatives of the B domain or Z domain of staphylococcal protein A (SPA). These derivatives contain amino acid substitutions that enable interaction with at least one domain of a human Factor VIII protein, while maintaining the structure and stability of the B domain or Z domain.
Career Highlights
Nygren has established himself as a key figure in the biotechnology sector. He is currently associated with Biovitrum AB, where he continues to innovate and contribute to advancements in his field. His work has garnered attention for its potential to enhance therapeutic strategies and improve understanding of protein interactions.
Collaborations
Throughout his career, Nygren has collaborated with esteemed colleagues such as Mathias Uhlén and Björn M Nilsson. These partnerships have further enriched his research and expanded the impact of his inventions.
Conclusion
Per-Åke Nygren's contributions to the field of biotechnology, particularly in bacterial receptor structures, highlight his innovative spirit and dedication to advancing scientific knowledge. His patents reflect a commitment to developing solutions that could have far-reaching implications in medicine and research.